​

Innoviva (INVA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

INVA Stock Forecast

Innoviva (INVA) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $55.00, with a high of $55.00 and a low of $55.00. This represents a 157.01% increase from the last price of $21.40.

$15 $23 $31 $39 $47 $55 High: $55 Avg: $55 Low: $55 Last Closed Price: $21.4

INVA Stock Rating

Innoviva stock's rating consensus is Hold, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (28.57%), 4 Hold (57.14%), 1 Sell (14.29%), and 0 Strong Sell (0.00%).

Hold
Total 7 0 1 4 2 Strong Sell Sell Hold Buy Strong Buy

INVA Price Target Upside V Benchmarks

TypeNameUpside
StockInnoviva157.01%
SectorHealthcare Stocks 24.81%
IndustryBiotech Stocks 65.78%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$55.00
Last Closing Price$21.40$21.40$21.40
Upside/Downside--157.01%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 251----1
May, 25--1--1
Apr, 25--1--1
Mar, 25--1--1
Feb, 25--1--1
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 07, 2025Scotiabank$55.00$17.64211.79%157.01%
Aug 08, 2022Morgan Stanley$13.00$14.72-11.68%-39.25%
Jul 15, 2022Morgan Stanley$12.00$14.37-16.49%-43.93%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 07, 2025ScotiabankOutperforminitialise
Jun 18, 2024Cantor FitzgeraldOverweightinitialise
Aug 08, 2022Morgan StanleyUnderweightUnderweighthold
Jul 15, 2022Morgan StanleyUnderweightUnderweighthold
Feb 23, 2022Morgan StanleyUnderweightUnderweighthold

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.21$3.24$3.07$2.92$0.37----
Avg Forecast$2.19$2.02$3.72$1.67$0.43$1.72$1.78$2.15$2.78
High Forecast$2.26$2.08$3.85$1.67$0.43$1.72$1.78$2.15$2.78
Low Forecast$2.12$1.96$3.58$1.67$0.43$1.72$1.78$2.15$2.78
Surprise %0.91%60.40%-17.47%74.85%-13.95%----

Revenue Forecast

$250M $300M $350M $400M $450M $500M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$336.79M$391.87M$331.34M$310.46M$358.71M----
Avg Forecast$260.58M$292.18M$337.53M$300.14M$353.70M$353.05M$377.95M$407.00M$482.60M
High Forecast$266.74M$299.08M$346.72M$300.14M$353.70M$353.05M$384.57M$407.00M$482.60M
Low Forecast$254.43M$285.28M$328.33M$300.14M$353.70M$353.05M$371.32M$407.00M$482.60M
Surprise %29.25%34.12%-1.83%3.44%1.42%----

Net Income Forecast

$0 $80M $160M $240M $320M $400M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$224.40M$368.84M$213.92M$179.72M$23.39M----
Avg Forecast$205.12M$72.87M$93.40M$113.26M$36.92M$148.99M$154.64M$186.78M$241.52M
High Forecast$246.15M$75.11M$112.07M$135.91M$36.92M$148.99M$154.64M$186.78M$241.52M
Low Forecast$164.10M$70.64M$74.72M$90.61M$36.92M$148.99M$154.64M$186.78M$241.52M
Surprise %9.40%406.14%129.05%58.68%-36.65%----

INVA Forecast FAQ

Is Innoviva stock a buy?

Innoviva stock has a consensus rating of Hold, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 4 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Innoviva is a neutral investment for most analysts.

What is Innoviva's price target?

Innoviva's price target, set by 7 Wall Street analysts, averages $55 over the next 12 months. The price target range spans from $55 at the low end to $55 at the high end, suggesting a potential 157.01% change from the previous closing price of $21.4.

How does Innoviva stock forecast compare to its benchmarks?

Innoviva's stock forecast shows a 157.01% upside, outperforming the average forecast for the healthcare stocks sector (24.81%) and outperforming the biotech stocks industry (65.78%).

What is the breakdown of analyst ratings for Innoviva over the past three months?

  • June 2025: 100.00% Strong Buy, 0% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.

What is Innoviva’s EPS forecast?

Innoviva's average annual EPS forecast for its fiscal year ending in December 2025 is $1.72, marking a 364.86% increase from the reported $0.37 in 2024. Estimates for the following years are $1.78 in 2026, $2.15 in 2027, and $2.78 in 2028.

What is Innoviva’s revenue forecast?

Innoviva's average annual revenue forecast for its fiscal year ending in December 2025 is $353.05M, reflecting a -1.58% decrease from the reported $358.71M in 2024. The forecast for 2026 is $377.95M, followed by $407M for 2027, and $482.6M for 2028.

What is Innoviva’s net income forecast?

Innoviva's net income forecast for the fiscal year ending in December 2025 stands at $148.99M, representing an 536.94% increase from the reported $23.39M in 2024. Projections indicate $154.64M in 2026, $186.78M in 2027, and $241.52M in 2028.